Catalog No.
RHC22901
Species reactivity
Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:50-1:200, IHC: 1:50-1:100, WB: 1:500-1:1000
Target
Tyrosine 3-hydroxylase, TYH, Tyrosine 3-monooxygenase, TH
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P07101
Applications
IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1K84
Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects., PMID:40517443
Advances in the Management of Relapsed/Refractory CLL and Richter Transformation., PMID:40517442
T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma., PMID:40517438
A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma., PMID:40517417
Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI., PMID:40517176
Advances in molecular pathology and therapy of non-small cell lung cancer., PMID:40517166
Evaluating the Role of CAR-T Cell Therapy in the Context of Current Therapy Options for Patients With Relapsed or Refractory Follicular Lymphoma., PMID:40516919
The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities., PMID:40516902
Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations., PMID:40516870
Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma., PMID:40516820
Efficacy of waitlist desensitization for lung candidates is limited by antibody rebound., PMID:40516662
WAYPOINT: Are we there yet for patients with nasal polyposis?, PMID:40516522
CD38-targeted antibody-polymer drug conjugates for enhanced treatment of multiple myeloma., PMID:40516447
The immune response of Boschveld chickens to a Newcastle disease vaccination program designed for commercial layers., PMID:40515962
Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia., PMID:40515863
Response to telitacicept in optic neuritis associated with Sjogren's syndrome: a case report and literature review., PMID:40515854
Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance., PMID:40515788
A comparison of JC virus assay performance provided with originator and biosimilar natalizumab., PMID:40515643
Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?, PMID:40515642
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances., PMID:40515614
An evaluation of datopotamab deruxtecan for the treatment of non-small cell lung cancer., PMID:40515573
A Randomized, Double-Blind, 2-Treatment, 2-Period, Crossover Phase 1 Study to Compare the Pharmacokinetics, Safety and Tolerability of 60 IU/Kg of Abcertin and Cerezyme in Healthy Volunteers Following a Single Intravenous Administration., PMID:40515481
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer., PMID:40515479
Pooled biomarker analysis of the association of baseline T regulatory cells with response and T-cell recovery profiles with blinatumomab treatment., PMID:40515477
Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report., PMID:40514742
Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study., PMID:40514717
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study., PMID:40514709
Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients., PMID:40514707
A New Vaccine Candidate Expressing JUNV GP1-GP2 Against Argentine Hemorrhagic Fever Based on Baculovirus Surface Display., PMID:40514553
[Modern systemic treatment-bispecific antibodies and CAR-T cell therapy : Clinical management, mechanisms of action, outcomes]., PMID:40514410
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India., PMID:40514308
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma., PMID:40514070
Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer., PMID:40514068
Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses., PMID:40513829
Preparation and antitumor of hyaluronic acid-human serum albumin-indocyanine green-paclitaxel nanoparticles., PMID:40513730
Editorial: Endomysial Antibodies for a No-Biopsy Diagnosis of Coeliac Disease-The Jury Is Still out. Authors' Reply., PMID:40512983
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance., PMID:40512837
Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer., PMID:40512778
Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type., PMID:40512776
The Entry of Zika Virus into the Cells and Its Implication for Antiviral Therapy., PMID:40512550
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma., PMID:40512454
Methods for Evaluation of Antivirals and Neutralizing Antibodies Against Tick-Borne Encephalitis Virus., PMID:40512316
A novel killed oil adjuvanted bovine viral diarrhea virus vaccine protects from viremia and clinical manifestations: an immune response and challenge study in cattle., PMID:40512232
Immune-modulatory effects of Spindlin-1 inhibitors., PMID:40512144
Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer., PMID:40511831
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC., PMID:40511820
Perspectives on T-cell engaging therapies in relapsed/refractory indolent non-Hodgkin lymphoma., PMID:40511598
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model., PMID:40511536
Children with hepatitis B virus infections, Democratic Republic of the Congo., PMID:40511401
A Case of Acute Kidney Injury During Eltrombopag Use Successfully Treated With Plasma Exchange in Addition to Antithrombotic Therapy., PMID:40510611
For research use only. Not for human or drug use.
